Objective: To describe maternal and perinatal outcomes among pregnant women with suspected Ebola virus disease (EVD) in Sierra Leone. 
| INTRODUCTION
The 2014 Ebola virus disease (EVD) epidemic was the largest Ebola outbreak in history, severely affecting multiple countries in West Africa. Although there have been recent advances in treatment of EVD, management has usually consisted of supportive care, with mortality ranging from 25% to 90%. [1] [2] [3] [4] [5] [6] For the 2014 EVD epidemic, the Centers for Disease Control and Prevention (CDC) and WHO estimated that 28% of all EVD cases (including suspected, probable, and laboratory-confirmed) and 45% of only laboratory-confirmed cases died as of April 2016. 7 While data exist on EVD outcomes among the general population, information about outcomes among pregnant women is insufficient, with only a limited number of published reports. In the Democratic
Republic of the Congo, 9 of 82 EVD-positive pregnant women survived a 1976 outbreak 8, 9 and 1 of 15 EVD-positive pregnant women
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survived a 1995 outbreak. 8, 10 In these reports, perinatal mortality was universal, with spontaneous abortions occurring in 23%-67% of pregnancies and no reports of neonates born to EVD-positive women surviving beyond 19 days. 9 Prior to the 2014 EVD outbreak, Sierra Leone had one of the highest maternal mortality ratios in the world, estimated at 1100 maternal deaths per 100 000 live births. 11 Only one maternity hospital exists in Sierra Leone; this facility in Western Area serves as a tertiary referral center treating the most severely ill patients. EVD isolation units were established to evaluate and test people suspected of EVD in isolation from the community and other patients. Those testing positive for EVD were referred to Ebola Treatment Units (ETUs) for EVD management. Isolation units were intended to house patients temporarily and were not equipped to perform invasive procedures, such as cesarean deliveries. Given their limited resources, many isolation units and ETUs did not admit pregnant women owing to their need for specialized care and expected poor outcomes. Often, one isolation unit in a district would accept pregnant women and become the unofficial referral center.
Because information about pregnant women with EVD is limited, the aim of the present study was to describe the maternal and perinatal outcomes among pregnant women with suspected EVD in Sierra Leone to help guide improvements in the clinical management of this population. In a subanalysis, we obtained numbers of live births in the Western Area maternity hospital and calculated maternal mortality ratios (per 100 000 live births) and stillbirth rates (per pregnancies) during the first 6 months of the epidemic (July-December 2014) and the 6 months preceding the outbreak in Western Area (January-June 2014).
| MATERIALS AND METHODS

| RESULTS
We collected data on 192 pregnant women with suspected EVD from for Ebola virus (EVD-negative). Seven (3.6%) women had unknown test results due to lack of available testing, indeterminate results, or patient elopement. These women were not included in the EVDstatus specific analyses.
Demographic characteristics are shown in time in the isolation unit (prior to death or discharge), and the outcome of the mother and fetus after discharge is not known. Four women were admitted to the isolation unit during the second trimester and 1 woman was admitted at the beginning of the third trimester. The gestational age of the other 2 women was not known. e Alive at time of discharge from isolation unit. f One neonate was reported to be alive 2 mo after birth but survival has not been confirmed. (Table 2) .
We conducted a mortality subanalysis for the Western Area maternity hospital. Mortality did not differ in the Western Area isolation unit compared with non-Western Area isolation units for EVD-positive women (P=0.590) and EVD-negative women (P=0.144) ( Table 3) .
Among this hospital's general population, there was a 27% decrease in overall hospital admissions during the EVD outbreak compared with the 6 months prior to the facility's first suspected EVD patient in July 2014 ( Table 4 ). The facility-based maternal mortality ratio increased by 66% and the rate of stillbirths increased by 18% during the EVD outbreak compared with the 6 months prior to the EVD outbreak (Table 4) .
| DISCUSSION
These data represent the largest collection of information on pregnancy and perinatal outcomes for pregnant women with suspected EVD. We found that pregnant women are able to survive EVD infection, even after childbirth. Unfortunately, perinatal outcomes were extremely poor, and neonates born to EVD-positive women generally did not survive. This finding is consistent with publications and April 2015. 12 All of these women had spontaneous abortions or stillbirths except for one woman who had a live birth; however, this neonate died after 2 days. While treatment has typically been limited to supportive care, early access to treatment and recent advances in management may improve these poor survival rates. In January 2016, a study evaluating the efficacy of convalescent plasma for the treatment of EVD in Guinea found that mortality among pregnant women decreased after treatment. 13 Additionally, a neonate born to an EVD-positive woman (who died after delivery) was given the experimental drugs ZMapp (Mapp Biopharmaceutical, San Diego, CA, USA) and GS-5734 (Gilead Sciences, Foster City, CA, USA), survived, and was declared EVD-free. 14, 15 This provides some hope that new and improved interventions may improve outcomes and reduce neonatal mortality. 14, 15 While poor maternal and perinatal outcomes among EVDpositive women were not surprising, the poor outcomes for EVDnegative women, including maternal deaths and stillbirths, were more common than expected. Pregnant women in isolation units born at 38 wk of gestation on the day the mother presented to the hospital complaining of fever, headache, fatigue, weakness, vomiting, and abdominal pain. The mother died following delivery as a result of postpartum hemorrhage. e Includes 22 undelivered neonates from the 35 mothers who died, and totals for spontaneous abortion, stillbirth, and neonatal death. f Includes one stillbirth to an EVD-positive women who had an unknown outcome.
T A B L E 3 Maternal deaths according to location of isolation unit, Sierra Leone, 2014. during the height of the 2014 EVD outbreak were likely more severely ill than the average pregnant women seeking healthcare for labor or pregnancy complications and had fewer life-saving interventions available. Many of the EVD-negative women appeared to have infectious causes of death rather than the more common causes of maternal death, such as eclampsia and hemorrhage. 16 The high maternal mortality among EVD-negative pregnant women meeting the clinical criteria for suspected EVD may be more reflective of the illness or symptom severity of these women resulting from a non-EVD cause. One recent study in a nonpregnant population at an ETU in Sierra Leone found that nearly half of those presenting to the ETU as suspected EVD cases had other infectious causes such as malaria, enteric illnesses, or lower respiratory tract infections. 17 Determining the specific infection responsible for death and the contribution of but the impact is difficult to quantify. Given the chaotic setting during which data were collected, some data were incomplete. However, data quality improved as collection became prospective, reducing recall bias and improving standardization by using one collection tool across districts. Pregnancy status was primarily self-reported, which may have excluded some pregnant women. Similarly, outcomes of spontaneous abortion or stillbirth were determined by administrative records based on patient and healthcare provider reports, rather than documentation of gestational age. Our study population included pregnant women presenting to isolation units in only five districts and is not nationally representative. We attempted to follow up on the outcomes of pregnant women transferred to other facilities; however, we were unable to confirm the outcomes for 3 of 15 pregnant women.
Ebola test result
Attempts to classify the cause of death were limited by the minimal clinical information available and lack of comprehensive testing for EVD and other infectious diseases. Having only one negative EVD result was considered sufficient for classification as EVD-negative and no antibody testing was performed to identify EVD survivors with prior infection. EVD testing was not conducted or results were unavailable for neonates born to EVD-positive women, and EVD testing was not performed on stillbirths, as it was not standard of care at the time.
In conclusion, we found that among a population of pregnant women with suspected EVD in Sierra Leone, EVD-positive women had a significantly higher number of adverse pregnancy outcomes and maternal deaths than EVD-negative women. Although worse outcomes were not surprising for EVD-positive pregnant women, the outcomes of EVD-negative pregnant women were also poor. Although pregnant women with suspected EVD may be more ill than the general population of pregnant women, the high mortality highlights the widespread need to invest in maternal health services. Nationwide surveillance of EVD and other infectious diseases among pregnant women can improve understanding of the burden of these diseases to inform effective interventions to improve maternal and perinatal outcomes.
AUTHOR CONTRIBUTIONS
ML contributed to the conception of the study, data collection, data analysis, and writing and revising the manuscript. JJM contributed to the development of the first data collection tool, data collection, and revising the manuscript. FS contributed to planning and implementing the expansion of the project, data collection, and revising the manuscript. TO contributed to data collection and revising the manuscript.
SE contributed to the conception and design of the study, data analysis, and revising the manuscript. GWS and APK contributed to the conception of the study and revising the manuscript. APK contributed to the conception of the study, revising the manuscript, and obtaining
